Eton Pharmaceuticals/ETON

$4.47

0%
-
1D1W1MYTD1YMAX

About Eton Pharmaceuticals

Eton Pharmaceuticals, Inc. is a pharmaceutical company, which is developing, acquiring and commercializing products to address unmet needs in patients suffering from rare diseases. It has three commercial rare disease products, ALKINDI SPRINKLE for the treatment of adrenocortical insufficiency, Carglumic Acid for the treatment of hyperammonemia due to N-acetylglutamate synthase deficiency, and Betaine Anhydrous for the treatment of homocystinuria. It also has three additional product candidates in late-stage development. The Company is developing dehydrated alcohol injection, which has received Orphan Drug Designation for the treatment of methanol poisoning, ZENEO hydrocortisone autoinjector for the treatment of adrenal crisis, and ET-400. Its dehydrated alcohol injection product candidate is under review for the treatment of methanol poisoning. Its ZENEO hydrocortisone autoinjector product candidate is a needle-free autoinjector under development for the treatment of adrenal crisis.
Ticker
ETON
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
CEO
Sean Brynjelsen
Employees
28
Headquarters
Deer park, United States

ETON Metrics

BasicAdvanced
$114.69M
Market cap
52.79
P/E ratio
$0.08
EPS
1.19
Beta
-
Dividend rate

What the Analysts think about ETON

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 1 analysts.
123.71% upside
High $10.00
Low $10.00
$4.47
Current price
$10.00
Average price target

ETON Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-7.14% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$7M
-41.18%
Net income
$-500K
-111.11%
Profit margin
-7.14%
-118.88%

ETON Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 80%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.04
-$0.10
$0.18
-$0.02
-
Expected
$0.01
-$0.14
-$0.09
-$0.10
-$0.04
Surprise
300%
-28.57%
-300%
-80%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Eton Pharmaceuticals stock

Buy or sell Eton Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing